You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

zanubrutinib

Showing 51 - 66 of 66
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Waldenström Macroglobulinemia Trial in United States (Zanubrutinib)

No longer available
  • Waldenström Macroglobulinemia
  • Zanubrutinib
  • Mobile, Alabama
  • +19 more
Jun 8, 2021

Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6

Not yet recruiting
  • Grade 3b Follicular Lymphoma
  • +5 more
  • Biospecimen Collection
  • +9 more
  • (no location specified)
Jun 6, 2023

Mature B-cell Malignancies Trial in Japan (Zanubrutinib)

Recruiting
  • Mature B-cell Malignancies
  • Zanubrutinib
  • Nagoya, Aichi, Japan
  • +14 more
Feb 18, 2021

Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic Lymphoma Trial in China

Completed
Has Results
  • Relapsed or Refractory Chronic Lymphocytic Leukemia
  • Relapsed or Refractory Small Lymphocytic Lymphoma
  • Zanubrutinib
  • Beijing, Beijing, China
  • +15 more
Sep 29, 2021

B-cell Lymphoid Malignancies Trial in Australia, Korea, Republic of, United States (Zanubrutinib, Obinutuzumab)

Completed
Has Results
  • B-cell Lymphoid Malignancies
  • Fort Myers, Florida
  • +14 more
Mar 1, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Follicular Lymphoma (FL) Trial in Switzerland, United

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • Tucson, Arizona
  • +23 more
Dec 14, 2021

Marginal Zone Lymphoma, Follicular Lymphoma, DLBCL Trial in China (Zanubrutinib, Rituximab)

Completed
Has Results
  • Marginal Zone Lymphoma
  • +2 more
  • Harbin, Heilongjiang, China
  • +3 more
Oct 26, 2021

Refractory Mantle Cell Lymphoma, Relapsed Mantle Cell Lymphoma Trial in China (Zanubrutinib)

Completed
Has Results
  • Refractory Mantle Cell Lymphoma
  • Relapsed Mantle Cell Lymphoma
  • Zanubrutinib
  • Beijing, Beijing, China
  • +13 more
Oct 8, 2021

Waldenström's Macroglobulinemia (WM) Trial in China (Zanubrutinib)

Completed
Has Results
  • Waldenström's Macroglobulinemia (WM)
  • Zanubrutinib
  • Beijing, Beijing, China
  • +10 more
Mar 7, 2022

Idiopathic Multicentric Castleman's Disease Trial in Beijing (Zanubrutinib)

Recruiting
  • Idiopathic Multicentric Castleman's Disease
  • Zanubrutinib
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Feb 5, 2021

Hepatic Insufficiency & Healthy Subjects Trial in Miami, Orlando (Zanubrutinib)

Completed
  • Hepatic Insufficiency & Healthy Subjects
  • Zanubrutinib
  • Miami, Florida
  • +1 more
Apr 22, 2020

Mature B-Cell Malignancies Trial in Worldwide (BGB-11417, Zanubrutinib)

Recruiting
  • Mature B-Cell Malignancies
  • Stanford, California
  • +26 more
Dec 16, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Zanubrutinib, Ibrutinib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Little Rock, Arkansas
  • +144 more
Dec 3, 2021

Healthy Volunteers Trial in Adelaide (Zanubrutinib)

Completed
  • Healthy Volunteers
  • Zanubrutinib
  • Adelaide, South Australia, Australia
    CMAX
Nov 12, 2019

Lymphoma, Mantle-Cell Trial in Worldwide (Pirtobrutinib, Ibrutinib, Acalabrutinib)

Recruiting
  • Lymphoma, Mantle-Cell
  • Phoenix, Arizona
  • +158 more
Aug 15, 2022

Relapsed/Refractory Follicular Non-Hodgkin Lymphoma Trial in Worldwide (Zanubrutinib, Obinutuzumab)

Active, not recruiting
  • Relapsed/Refractory Follicular Non-Hodgkin Lymphoma
  • Atlanta, Georgia
  • +119 more
Feb 23, 2022